ASCO 2022 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO 2022 Conference Coverage

Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma

ASCO 2022 CHAARTED Trial: Eight-Year Survival Rates by Baseline Prognostic Groups in Pts With mHSPC: An Analysis From ECOG-ACRIN 3805

By ASCO 2022 Conference Coverage FEATURING Abhishek Tripathi

265 views

June 17, 2022

Comments 0

ASCO 2022 Bladder Cancer Highlights

ASCO 2022 Conference Coverage

G. Sonpavde

810 views

ASCO 2022 on Olaparib + Abiraterone as 1L Therapy for mCRPC: Pharmac…

ASCO 2022 Conference Coverage

A. Armstrong

264 views

ASCO 2022 on Safety & Clinical Activity of MEDI5752, a PD-1/CTLA-4 B…

ASCO 2022 Conference Coverage

L. Albiges

139 views

ASCO 2022 on the Clinical Outcomes & Safety of Enzalutamide + ADT in…

ASCO 2022 Conference Coverage

R. Szmulewitz

176 views

ASCO 2022 CHAARTED Trial: Eight-Year Survival Rates by Baseline Prog…

ASCO 2022 Conference Coverage

A. Tripathi

265 views

ASCO 2022 Defining "Platinum-Ineligible" Pts With Metastatic Urothel…

ASCO 2022 Conference Coverage

S. Gupta

259 views

ASCO 2022 MAIN-CAV: Phase III Randomized Trial of Maintenance Caboza…

ASCO 2022 Conference Coverage

S. Gupta

722 views

ASCO 2022 Highlights From Educational Sessions and Updates in Bladde…

ASCO 2022 Conference Coverage

P. Grivas

728 views

ASCO 2022 Ga-PSMA-11 PET Baseline Imaging as a Prognostic Tool for C…

ASCO 2022 Conference Coverage

P. Kuo

307 views

Lecture Summary - ASCO 2022 Real-World Treatment Patterns and Clinic…

ASCO 2022 Conference Coverage

G. Sonpavde

12 views

ASCO 2022 Real-World Treatment Patterns and Clinical Outcomes With 1…

ASCO 2022 Conference Coverage

G. Sonpavde

185 views

ASCO 2022 on Randomized Phase II Trial of Neoadjuvant ADT + Abirater…

ASCO 2022 Conference Coverage

D. Bastos

254 views

ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder …

ASCO 2022 Conference Coverage

G. Iyer

131 views

ASCO 2022 Maturation of Overall Survival in TIVO-3 With Long-Term Fo…

ASCO 2022 Conference Coverage

B. Rini

644 views